- Home
- TAK vs AU Comparison
TAK vs AU Comparison
Compare TAK & AU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TAK | AU |
|---|---|---|
| Founded | 1781 | 1944 |
| Country | Japan | United States |
| Employees | 47455 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.6B | 61.2B |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | TAK | AU |
|---|---|---|
| Price | $18.11 | $98.73 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $92.00 |
| AVG Volume (30 Days) | 2.8M | ★ 2.9M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | 2.90% | ★ 3.51% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.38 | $35.44 |
| Revenue Next Year | $1.02 | N/A |
| P/E Ratio | $41.25 | ★ $23.93 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.99 | $34.94 |
| 52 Week High | $18.90 | $129.14 |
Technical Indicators
Market Signals| Indicator | TAK | AU |
|---|---|---|
| Relative Strength Index (RSI) | 49.02 | 49.58 |
| Support Level | $17.65 | $80.83 |
| Resistance Level | $18.67 | $115.81 |
| Average True Range (ATR) | 0.27 | 4.26 |
| MACD | -0.00 | 1.70 |
| Stochastic Oscillator | 27.80 | 70.05 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About AU AngloGold Ashanti PLC
Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.